Santen Pharmaceutical Co(DE:SZD0)
€11.40+0.00 (+8.57%)
DE:SZD0
Santen Pharmaceutical Co Revenue
€11.40
At close:+0.00 (+8.57%)
Santen Pharmaceutical Co (SZD0) Revenue
0 Followers
Santen Pharmaceutical Co Revenue
Santen Pharmaceutical Co had a revenue of 74.33B in the quarter ending Sep 30, 2026, with 6.39%. This bring the company's revenue in the last twelve months to 300.74B, Increased 1.34%. In the fiscal year ending Mar 31, 2026, Santen Pharmaceutical Co had annual revenue of 309.21B with 3.07% growth.
- Revenue (ttm)
- 300.74B
- Revenue Growth
- -8.31%
- P/S Ratio
- 0.01
- Revenue/Employee
- EUR 77,926,213
- Employees
- 3,968
- Market Cap
- EUR 3.66B
Revenue Chart
Santen Pharmaceutical Co Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 309.21B | 9.21B | 3.07% |
| Mar 31, 2026 | 300.00B | -1.96B | -0.65% |
| Mar 31, 2025 | 301.96B | 22.93B | 8.22% |
| Mar 31, 2024 | 279.04B | 12.78B | 4.80% |
| Mar 31, 2023 | 266.26B | 16.65B | 6.67% |
| Mar 31, 2022 | 249.60B | 8.05B | 3.33% |
| Mar 31, 2021 | 241.56B | 7.53B | 3.22% |
| Mar 31, 2020 | 234.03B | 9.08B | 4.04% |
| Mar 31, 2019 | 224.94B | 25.85B | 12.98% |
| Mar 31, 2017 | 199.10B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.